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Abstract
Background We previously reported the development of pancreatic acinar cell metaplasia (PACM) in the glandular stomach 
of a duodenal contents reflux model (reflux model).
Aims We aimed to investigate the characteristics and histogenesis of PACM using a reflux model.
Methods A reflux model was created using 8-week-old male Wistar rats, which were killed up to 30 weeks postoperatively. 
Histological examination was performed to analyze the glandular stomach–jejunal anastomosis. Furthermore, electron 
microscopic images of PACM samples were compared with pancreatic and gastric glands removed from rats that had not 
undergone surgery. Immunostaining for α-amylase, HIK1083, TFF2, and Ki-67 was performed, and double fluorescent 
staining was carried out using antibodies against α-amylase and HIK1083, or α-amylase and TFF2.
Results In all reflux model rats, PACM was observed proximal to the glandular stomach–jejunal anastomosis, surrounded 
by pseudopyloric metaplasia. The number of chief cells was decreased in the deep part of the gland, where PACM occurred. 
Electron microscopy showed that PACM cells had greater numbers of rough endoplasmic reticulum tubules than chief cells, 
and exhibited pancreatic acinar cell morphology. Upon immunochemical staining, the regenerative foveolar epithelium and 
part of the pseudopyloric glands stained strongly positive for TFF2, whereas PACM cells were only weakly positive. Double 
fluorescent staining identified early lesions of PACM in the neck, which were double positive for α-amylase and TFF2, but 
negative for HIK1083.
Conclusions PACM could be induced by duodenal contents reflux. PACM originates from stem cells located in the neck of 
oxyntic glands during gastric mucosal regeneration.
Keywords Pancreatic acinar cell metaplasia · SPEM · Rat reflux model · Bile acids
Abbreviations
PACM  Pancreatic acinar cell metaplasia
GERD  Gastroesophageal reflux disease
H. pylori  Helicobacter pylori
SPEM  Spasmolytic polypeptide-expressing 
metaplasia
TFF2  Trefoil factor 2
HE  Hematoxylin and eosin
Introduction
Pancreatic acinar cell metaplasia (PACM) is a type of meta-
plasia that was initially reported in the early 1990s [1], and 
is mainly found in the gastric mucosa, along with less fre-
quently occurring intestinal and pseudopyloric metaplasia. 
PACM resembles pancreatic acinar cells, exocrine cells with 
basophilic cytoplasm, and eosinophilic coarse granules [1–3]. 
PACM is composed of pancreatic acinar cell-like cells, as 
observed in gastric mucosa, and differs from the ectopic pan-
creas that may contain pancreatic ducts or islets of Langerhans 
[1, 4]. Immunohistochemical staining is reported to be positive 
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for lipase, trypsin, chymotrypsin, and α-amylase for PACM 
[1, 2, 4–8].
PACM may be observed in humans with healthy mucosa 
and atrophic gastritis [1, 9] but is reported to be more fre-
quently observed in the gastric body of Barrett’s epithelium 
and in autoimmune gastritis [10–12]. Reported incidence rates 
of PACM were 38.0% in Barrett’s epithelium [10], 50.0% in 
autoimmune gastritis, 6.6% in atrophic gastritis, and 2.7% in 
normal mucosa [9]. On the other hand, it has been reported 
that PACM is not associated with symptoms of gastroesopha-
geal reflux disease (GERD), histological findings of esophagi-
tis, or chronic gastritis [12]. Therefore, it has been hypoth-
esized that PACM is not acquired and that “metaplasia” is not 
a suitable term for PACM [12].
Metaplasia refers to the conversion of one cell type to 
another [13]. Types of metaplasia that occur in the stomach 
include intestinal and pseudopyloric metaplasia. In intestinal 
metaplasia, part of the gastric glands changes to intestinal 
epithelium and is associated with gastric cancer. It is also 
associated with the chronic inflammation and atrophy of the 
gastric mucosa due to Helicobacter pylori (H. pylori) infec-
tion [14]. The pseudopyloric metaplasia is associated with 
gastric inflammation due to H. pylori infection and gastric 
mucosal damage such as gastric ulcer [15–17]. In humans, 
pseudopyloric metaplasia, pyloric glands stain MUC6 positive 
[18–20], whereas in rats it stains positive for HIK1083, a pro-
tein expressed in mucous  neck cells and pyloric glands [21].
We have previously reported a connection between the 
onset of gastric and esophageal adenocarcinoma and the bile 
acids contained in duodenal contents, using various rat duo-
denal reflux models [22–25]. In one of our reflux models, 
we earlier reported the development of cardiac-type mucosa 
in the esophagus following surgical procedures that caused 
reflux of gastric fluid, including duodenal contents, into the 
esophagus [25]. We also reported the development of PACM 
in the glandular stomach in this model [26]. In the present 
study, we examined the histogenesis of PACM using a rat 
model, in which all duodenal contents were refluxed into the 
glandular stomach, similar to the model above. Further, we 
explored the relationship between PACM and spasmolytic pol-
ypeptide-expressing metaplasia (SPEM), which occurs during 
gastric mucosal regeneration [27, 28] and has been reported 
to be associated with carcinogenesis [29, 30]. Trefoil factor 
2 (TFF2) was used as a SPEM marker, which is expressed 
in parts of pseudopyloric metaplasia and foveolar epithelium 
[31], while HIK1083 was used as a marker for pyloric gland-
type cells.
Methods
Creation of a Rat Duodenal Contents Reflux Model
As previously reported, we created a duodenal contents 
reflux model using 12 male Wistar rats weighing approxi-
mately 250 g at 8 weeks of age using surgical techniques 
to allow reflux of duodenal contents into the stomach [22]. 
The procedure is summarized in Fig. 1. Briefly, an upper 
midline incision was made and the surgical procedure 
was performed under general anesthesia with isoflurane 
(Wako, Osaka, Japan). As in previous reports, the glandu-
lar stomach and duodenum were dissected at the oral side 
of the duodenal papilla and the duodenal stump was left 
as a blind stump. In addition, the jejunum was resected 
2 cm from the ligament of Treitz on the anal side, endo-
anastomosis of the oral end of the jejunum to the greater 
curvature of the glandular stomach was performed, and 
an operation to anastomose the anal end of the jejunum to 
the stump of the glandular stomach and the duodenum was 
performed [22]. Rats that underwent surgery started drink-
ing water 12 h postoperatively, and meals were initiated 
at 36 h postoperatively. Five rats were killed at 4 weeks 
postoperatively, two at 8 weeks postoperatively, two at 
25 weeks postoperatively, and three at 30 weeks postop-
eratively. In addition, five 25-week-old rats that had not 
undergone surgery were killed as controls.
Fig. 1  Rat duodenal reflux model. A preoperative image is shown 
on the left, while the right half illustrates the surgically induced rat 
duodenal contents reflux model used in this study. Resection was 
performed on structures highlighted by double lines, making a blind 
stump (b). Anastomosis was performed between (a) and (d), as well 
as (c) and (e). T, ligament of Treitz; F, forestomach; G, glandular 
stomach
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Histological Examination
The stomach, including the glandular stomach–jejunal 
anastomosis, was excised from the killed animals, and 
both, the stomach and pancreas, were excised from the 
control rats. Excised tissues were fixed in 10% buffered 
formalin for 24 h. After a paraffin block, fixed tissues were 
sliced into 2 μm sections and histologically examined fol-
lowing hematoxylin and eosin (HE) staining.
Electron Microscopy
Electron microscopy was performed by Tokai Electron 
Microscopy, Inc. (Nagoya, Japan). Tissue samples of 
approximately 2 mm3 were resected from the vicinity of 
the glandular stomach–jejunal anastomosis, a site of fre-
quent localization of PACM, from rats 25 weeks postoper-
atively, while tissues of the glandular stomach mucosa and 
pancreas were resected from the control rats at 25 weeks 
of age. The cells were permeabilized and fixed in 2% para-
formaldehyde and 2% glutaraldehyde. After washing, cells 
were fixed with 2% osmium tetroxide followed by dehydra-
tion with alcohol. Infiltration with propylene oxide and 
resin embedding (Quetol-812; Nisshin EM Co., Tokyo, 
Japan) were performed. The slices were further cut into 
1.5 μm sections with a glass knife and stained with 0.5% 
toluidine blue. Ultra-thin slicing was performed at a thick-
ness of 70 nm using a diamond knife. The primary stain-
ing was performed with 2% uranyl acetate and the sec-
ondary staining was performed with a lead stain solution 
(Sigma-Aldrich Co., Tokyo, Japan). Stained sections were 
observed using a transmission electron microscope (JEM-
1400Plus; JOEL Ltd., Tokyo, Japan), and digital images 
were acquired using a CCD camera (3296 × 2472 pixels, 
EM-14830RUBY2; JEOL Ltd., Tokyo, Japan).
Immunohistochemical Staining
Immunohistochemical staining was performed using anti-
bodies against α-amylase, HIK1083, TFF2, and Ki-67. The 
following primary antibodies were used: anti-α-amylase to 
stain pancreatic acinar cells (dilution ratio: 1:1000; Cell 
Signaling technology, Danvers, USA, cat.#3796S), anti-
HIK1083 for staining pyloric mucous  cells (dilution ratio: 
1:10; Kanto Kagaku, Tokyo, Japan, cat.#908G1659), anti-
TFF2 as a marker for SPEM (dilution ratio: 1:100; Abcam, 
Cambridge, England, cat.#ab239488), and anti-Ki-67 as a 
marker for cell proliferation (dilution ratio: 1:100; Abcam, 
Cambridge, England, cat.#ab16667). An automated device 
was used for immunohistochemical staining (Ventana Dis-
covery XT, Roche Diagnostics K.K., Tokyo, Japan).
Fluorescence Staining
The gastric mucosa isolated from the animals of the reflux 
model was fluorescently stained for a combination of either 
α-amylase and TFF2, or α-amylase and HIK1083. The gas-
tric mucosa and pancreas derived from the control animals 
were fluorescently stained for TFF2. Primary antibodies 
used have been listed in the immunohistochemical staining 
protocol. Alexa Fluor 488 goat anti-rabbit IgG (dilution 
ratio: 1:200; Invitrogen, Carlsbad, USA, cat.#1212189) 
and Alexa Fluor 594 goat anti-mouse IgG (dilution ratio: 
1:200; Invitrogen, Carlsbad, USA, cat.#1985396) were 
used as the secondary antibodies, and DAPI (dilution 
ratio: 1:1000; Wako, Osaka, Japan, cat.#STQ7716) was 
used for the nuclear staining. The staining was observed 
using an automated immunohistochemical staining device 




Our results showed that PACM occurred near the glandu-
lar stomach–jejunal anastomosis in all animals of reflux 
model. The PACM cells were sporadically distributed from 
the neck to the bottom of the oxyntic glands (Fig. 2a, b) 
and were positive for α-amylase (Fig. 2c). Proliferating 
cells positive for Ki-67 were more common in the neck 
of gastric oxyntic glands, but infrequent in small lesions 
of PACM (Fig.  2d). Interestingly, large aggregates of 
α-amylase-positive PACM cells with a budding and sac-
like appearance (Fig. 2e–g), which were developed in the 
deeper parts of the oxyntic glands, showed slightly higher 
Ki-67 indices (Fig. 2h).
Electron Microscopy Images
As shown by toluidine blue staining, PACM cells located 
around the neck of the oxyntic gland resembled a nor-
mal oxyntic gland with simple tubular gland morphology 
(Fig. 3a). However, PACM near the bottom of the oxyntic 
gland showed acinar structure, similar to a normal exocrine 
pancreas. Many zymogen granules were observed in the 
apical cytoplasm of cells present in PACM (Fig. 3b). The 
PACM cells were larger than chief cells (Fig. 3c) and had a 
higher resemblance to pancreatic acinar cells (Fig. 3d) than 
to chief cells (Fig. 3b–d). Moreover, the rough endoplasmic 
reticulum was more developed in PACM and pancreatic aci-
nar cells than in chief cells (Fig. 3b–d).
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Association Between PACM and SPEM
TFF2-positive cells were partly seen in the gastric oxyn-
tic mucosa far from the anastomotic site of reflux model 
animals (Fig. 4a). In the pancreas, acinar cells but not islet 
cells of Langerhans were positive for TFF2 (Fig. 4b). The 
PACM was detected in the gastric oxyntic mucosa derived 
from reflux model animals (Fig. 4c). Strong TFF2 staining 
was observed in foveolar epithelial cells with regenerative 
changes, while PACM cells stained weakly (Fig. 4d). Fur-
ther, pseudopyloric metaplasia cells with a bright cytoplasm 
were observed around PACM (Fig. 4c). The pseudopyloric 
metaplasia tested positive for HIK1083 (Fig. 4e). In the 
deeper part of the gland, where PACM and pseudopyloric 
glands were located, chief cells either decreased in number 
or completely disappeared (Fig. 4f). PACM was not observed 
in the glandular stomach in control rats. No neoplasms, such 
as dysplasia or cancer, were observed in any of the animals 
of reflux models during the study period.
Double Fluorescent Staining
Intense TFF2 immunoreactivity was observed in regenera-
tive gastric foveolar epithelium and accessory cells in the 
luminal side of PACM, whereas cells of the PACM proper 
showed comparably weaker immunoreactivity (Fig. 5a, b). 
All PACM cells stained positive for α-amylase (Figs. 5c, 
6c), and pseudopyloric metaplasia around PACM was posi-
tive for HIK1083 (Fig. 6b). Fluorescence signals of TFF2 
and α-amylase overlapped in PACM cells (Fig. 5d), but co-
localization of α-amylase and HIK1083 was not observed by 
double fluorescent staining (Fig. 6d). 
Discussion
PACM was observed near the glandular stomach–jejunal 
anastomosis in all reflux model rats 4 weeks postopera-
tively. It was distributed from the neck to the bottom of the 
oxyntic gland. TFF2 was weakly expressed in PACM. Elec-
tron microscopy revealed that PACM cells formed a tubular 
gland, similar to the oxyntic gland, in the neck part of the 
gastric mucosa. These results suggested that PACM cells 
Fig. 2  Hematoxylin and eosin (HE) staining and immunohistochemi-
cal staining of α-amylase and Ki-67 in pancreatic acinar cell metapla-
sia. Tissue slices of pancreatic acinar cell metaplasia (PACM) derived 
from reflux model rats 4  weeks postoperatively were subjected to 
staining with hematoxylin and eosin (HE) (a, b, e, f), and antibod-
ies against α-amylase (c, g) or Ki-67 (d, h). Arrows indicate small 
lesions of PACM. Each scale bar represents 200 µm
Fig. 3  Toluidine blue staining and electron microscopy imaging. 
PACM from the reflux model 25 weeks postoperatively was stained 
with toluidine blue on 1.5 µm thin sections derived from regions sur-
rounding the glandular stomach–jejunal anastomosis (a). Ultra-thin 
slices of reflux model PACM (b), chief cells (c), and pancreatic aci-
nar cells (d) were contrasted with 2% uranyl acetate and a lead stain 
solution. Each scale bar represents 200 µm in a and 5 µm in b–d 
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probably originate from stem cells present in the neck of 
the oxyntic gland during regeneration after mucosal injury 
caused by duodenal contents reflux [32, 33]. In the deeper 
part of the oxyntic gland, PACM showed a budding, sac-
like appearance, and a higher Ki-67 index compared to the 
smaller PACM lesions located at the neck. These findings 
suggested that the smaller PACM lesions in the neck region 
probably migrate downward, enhance proliferative activity, 
and develop budding acinar structures.
The precise molecular mechanism underlying the devel-
opment of PACM remains unknown. Because PACM is 
observed in children without inflammation or intestinal 
metaplasia [4, 12, 34], it may be a remnant of the fetal period 
and has been reported to be congenital [5]. However, our 
results from this study suggest that at least some cases of 
PACM could be acquired. In the present study, pseudopy-
loric metaplasia, which consists of pyloric-type mucous 
glands, was present in the background of PACM. In human 
cases, cardiac-type mucosa is often observed surrounding 
PACM [1, 8]. Moreover, PACM could be considered an 
aberrant differentiation phenotype of chief cell precursors 
as there is some ultrastructural resemblance between gastric 
chief cells and pancreatic acinar cells [8]. Mucous neck cells 
Fig. 4  Immunostaining of pancreatic acinar cell metaplasia developed 
in duodenal content reflux model. Gastric oxyntic mucosa far from 
the anastomotic site of the reflux model 25 weeks postoperatively (a) 
and pancreas tissue of the control rats (b) were stained with TFF2. 
Tissue slices of PACM derived from the reflux model were subjected 
to staining with HE (c), TFF2 (d) and HIK1083 (e). HE staining of 
the deeper part of the gland (f). Arrows indicate PACM. Each scale 
bar represents 200 µm
Fig. 5  Double fluorescent staining of TFF2 and α-amylase. Tis-
sue slices were stained with HE (a), and antibodies against TFF2 
(red) (b), or α-amylase (green) (c). A composite image of TFF2 and 
α-amylase staining is shown in (d). Nuclei were stained with DAPI 
(blue). Each scale bar represents 200 µm
Fig. 6  Double fluorescent staining of HIK1083 and α-amylase. Tis-
sue slices were stained with HE (a), or antibodies against HIK1083 
(red) (b), and α-amylase (green) (c). A composite image of HIK1083 
and α-amylase staining is shown in (d). Nuclei were stained with 
DAPI (blue). Each scale bar represents 200 µm
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are reported to be the precursors of chief cells [26]. Since 
the PACM cells, as well as mucous neck cells, were positive 
for TFF2 in the regenerative mucosa in the animals of reflux 
model, and because the expression pattern of a mucous neck 
cell marker (HIK1083) and a PACM marker (α-amylase) did 
not overlap, we hypothesize that the TFF2-positive, regen-
erative cells could differentiate bidirectionally into PACM 
and pseudopyloric metaplasia.
In 1999, Schmidt et al. reported that TFF2 was expressed 
in metaplastic cells adjacent to the gastric cancer in the 
stomach [35]. This was the first study to report the TFF2- 
and MUC6-positive pyloric gland in SPEM [36]. SPEM 
occurs during the acute damage to the gastric mucosa and 
gastric ulceration caused by drugs such as DMP777, L635, 
or high-dose tamoxifen in addition to H. pylori infection 
[29, 37, 38] and plays a role in regeneration in response to 
gastric mucosal injury [29, 39, 40]. While SPEM associ-
ated with acute gastric mucosal injury contributes to gastric 
mucosal regeneration, the continued presence of SPEM in 
chronic inflammatory conditions may lead to gastric can-
cer [30]. Kaise et al. reported that TFF2 was predominantly 
expressed in regenerative foveolar epithelium and partially 
in the pyloric glands in 18 gastric ulcer patients [31]. In 
the present study, TFF2 was also expressed in the foveolar 
epithelium of the gastric mucosa near the glandular stom-
ach–jejunal anastomosis and in some pyloric-type gland 
cells around PACM. These pyloric-type gland cells positive 
for TFF2 appear to correspond to SPEM. However, because 
fluorescence signals of HIK1083 and TFF2 did not com-
pletely co-localized, SPEM and pseudopyloric metaplasia 
are not the same lesions in the strict sense.
In the present study, PACM was induced by the reflux of 
duodenal juices into the glandular stomach of rats. Earlier, 
we succeeded in inducing PACM by long-term adminis-
tration of proton pump inhibitors (PPI), as well as in  the 
reflux model [41]. Furthermore, the study compared the inci-
dence of PACM between a placebo group and a PPI-treated 
group, using a rat reflux model of the esophagogastric junc-
tion, showing that the occurrence of PACM significantly 
increased in the PPI-treated group [42]. In humans, PACM is 
observed in cases of autoimmune and atrophic gastritis [9]. 
These results suggest that a low acid content in stomach may 
be related to the development of PACM. The duodenal reflux 
contains bile juice, which in humans contains approximately 
60% glycine-conjugated bile acid with an acid dissociation 
coefficient (pKa) ranging from 4 to 5, approximately 20% 
taurine-conjugated bile acids with a pKa of approximately 
2, and the unconjugated bile acids [43, 44]. Even in healthy 
subjects, duodenal contents flow back into the stomach after 
eating, but the pH in the stomach is approximately 2, and 
the acids other than taurine-conjugated bile acids precipi-
tate. Moreover, glycine-conjugated bile acids do not pre-
cipitate under mild acidic conditions (pH > 4). The bile acid 
concentrations in gastric juice are approximately four times 
greater than under pH > 4 [43, 44]. It has been reported that 
in humans, the bile acid concentrations increased in gas-
tric juice in response to PPI administration [45]. Since the 
esophagogastric junction is located on the dorsal side of the 
body, when a person lies down in the supine position imme-
diately after eating, the esophagogastric junction is exposed 
to bile acid reflux. Since bile acids are involved in the onset 
of Barrett’s esophagus [24, 46–48] and PACM too is sug-
gested to be associated with Barrett’s esophagus, bile acids 
may be associated with PACM.
In conclusion, our results suggested that at least some of 
the cases of PACM could be acquired. Further, some cases 
of PACM were associated with the gastric mucosal dam-
age due to the reflux of duodenal contents containing bile 
acids. In addition, PACM and pseudopyloric metaplasia 
might originate from stem cells in the neck of the oxyntic 
glands. However, since fluorescence signals of HIK1083 
and α-amylase did not co-localize, we hypothesize that upon 
regeneration of gastric mucosa, the stem cells of the neck 
may differentiate bidirectionally into PACM and pseudopy-
loric metaplastic lineages.
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